Search for: "MDS PHARMA SERVICES (US), INC."
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
28 Oct 2011, 4:30 am
., Nos. 04–MD–1603 (SHS), 08 Civ. 3380(SHS), 2011 WL 4469494 (S.D.N.Y. [read post]
28 Oct 2011, 4:30 am
., Nos. 04–MD–1603 (SHS), 08 Civ. 3380(SHS), 2011 WL 4469494 (S.D.N.Y. [read post]
6 Oct 2010, 5:56 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKIntellectual PropertyGeneric Drug Makers Did Not Infringe 'Method-of-Use' Contraceptive PatentBayer Schera Pharma AG v. [read post]
25 Jun 2015, 5:00 am
Md. [read post]
25 Jan 2010, 5:00 am
Rev. 2550, 2550 (June 2001).AlabamaEx parte Household Retail Services, Inc., 744 So.2d 871, 880 n. 2 (Ala. 1999); Ex parte Exxon Corp., 725 So.2d 930, 933 n.3 (Ala. 1998).AlaskaWe didn’t find anything useful along these lines under Alaska law.ArizonaOsuna v. [read post]
7 Feb 2019, 3:03 pm
MD Anderson ALJ Ruling. [read post]
19 Feb 2016, 11:57 am
Aegis Defense Services, LLC, 976 F. [read post]
17 Sep 2009, 4:30 am
Medtronic, Inc., 128 S. [read post]
8 Feb 2017, 3:09 am
(Appeal from MD State Court) Anticipation/Obviousness: Google Inc., et al. v. [read post]
16 Jan 2017, 5:44 pm
(Appeal from MD State Court) Anticipation/Obviousness: Google Inc., et al. v. [read post]
30 Jun 2016, 10:44 am
Md. [read post]
11 Jan 2008, 9:00 am
China is liable for copyright infringement because it provided search and linking services that directed users to sound recordings Yahoo! [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), … [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
24 Feb 2011, 1:49 pm
” Slip op. 2 (ordinarily we’d use the Westlaw pagination, but for some bizarre reason WL doesn’t provide any for Arkansas slips). [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal… [read post]
22 Dec 2009, 8:57 pm
Purdue Pharma, 438 F.3d at 1136. [read post]
18 Dec 2008, 10:36 pm
Astellas Pharma, US., Inc., 2007 WL 2137782, at *3-4 (E.D. [read post]
16 Aug 2007, 7:20 am
Astellas Pharma, US., Inc., 2007 WL 2137782 (E.D. [read post]
